Skip to main content
. 2024 May 8;18(Suppl 2):959–976. doi: 10.1007/s12072-024-10663-9

Table 1.

Targets for lifestyle therapy in people with MAFLD

graphic file with name 12072_2024_10663_Tab1_HTML.jpg

Arrows indicate strength of evidence in MAFLD. Double solid arrow = strong evidence for superior benefit in people with MAFLD; single solid arrow = strong evidence for benefit in people with MAFLD; double dashed arrow = likely superior benefit in people with MAFLD based on evidence from related metabolic conditions; single dashed arrow = likely benefit in people with MAFLD based on evidence from related metabolic conditions; double tilda(≈) = strong evidence for minimal/no benefit; ? = insufficient data